(Q52741196)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

On the biological properties of alkynyl phosphine gold(I) complexes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Malte Kokoschka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

9

Stefan Wölfl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Andreas Meyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Christoph P Bagowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Maria Stefanopoulou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hamed Alborzinia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Suzan Can

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Danielle H Vlecken

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

William S Sheldrick

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

29 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

Angewandte Chemie International Edition

9 February 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

8895-8899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

Chrysotherapy: a synoptic review

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Protein targets for anticancer gold compounds: mechanistic inferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Targeting proteins with metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Metal complexes in medicine with a focus on enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Gold compounds as therapeutic agents for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Gold-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Applications of gold(I) alkynyl systems: a growing field to explore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Antitumor activity of diethynylfluorene derivatives of gold(I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

The thioredoxin system—From science to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Basis Set Exchange: A Community Database for Computational Sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Real-time monitoring of cisplatin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Organometallic ruthenium(II) arene compounds with antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

The angiogenic process as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Catch of the day: zebrafish as a human cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Thioredoxin and thioredoxin reductase: current research with special reference to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202939

21 January 2018

Identifiers

DOI

10.1002/ANIE.201202939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22848030%20AND%20SRC:MED&resulttype=core&format=json

release_44qao2jklje3pbvfutpk7jnm5a

9 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/44qao2jklje3pbvfutpk7jnm5a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference